CDH23 Gene Deafness Autosomal Recessive Type 12 NGS Genetic DNA Test
Introduction
The CDH23 Gene Deafness Autosomal Recessive Type 12 NGS Genetic DNA Test is a specialized diagnostic tool that assesses genetic mutations linked to hearing loss. This test is particularly important for individuals with a family history of deafness or those experiencing unexplained hearing difficulties. By utilizing Next-Generation Sequencing (NGS) technology, this test provides detailed insights into the genetic factors contributing to auditory disorders.
What the Test Measures
This genetic test focuses on identifying mutations in the CDH23 gene, which plays a crucial role in the function of hair cells in the inner ear. Mutations in this gene are known to cause autosomal recessive forms of deafness, particularly in individuals who inherit two copies of the mutated gene from their parents.
Who Should Consider This Test
Individuals who may benefit from the CDH23 Gene Deafness NGS Genetic Test include:
- Those with a family history of hearing loss.
- Individuals experiencing unexplained hearing difficulties.
- Patients with related symptoms such as balance issues or tinnitus.
Benefits of Taking the Test
Taking the CDH23 Gene Deafness Test offers several advantages:
- Identifies genetic predispositions to hearing loss.
- Informs family planning decisions.
- Guides treatment options and management strategies for hearing disorders.
- Provides peace of mind through genetic understanding.
Understanding Your Results
Once the test is completed, patients will receive a comprehensive report detailing the presence or absence of mutations in the CDH23 gene. It is essential to consult with a genetic counselor or an ENT doctor to interpret the results accurately and discuss potential next steps.
Test Pricing
Price Type | Amount (NGN) |
---|---|
Discount Price | 400,000 NGN |
Regular Price | 560,000 NGN |
Book Your Test Today!
Don’t wait to understand your genetic risks. Book the CDH23 Gene Deafness Autosomal Recessive Type 12 NGS Genetic DNA Test today! For more information or to schedule your appointment, please call or WhatsApp us at +2348077798758.
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS7.
Specialty: ENT Doctor, Department: Genetics, Method: NGS Technology, Disease Type: Ear Nose Throat Disorders.